OPTH OPTH
Company Profile ↓Company Overview
OPTH (OPTH) is a publicly traded company listed on with a market capitalization of $16.27M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 74.2% CAGR over the past five years.
Recent Developments
- Sep 2025 Revenue of $426.30K (+9.4% YoY); net profit $-3.71M.
- Trailing 12 Months Year-on-year growth — revenue +9.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 74.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 74.15% |
| 1 Year: | 9.35% |
Stock Price Performance
| 1 Year: | -16.94% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | +8.84% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- RSI (14)53.41 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 74.2% over 5 years.
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 61.24K | 196.39K | -64.03K | 0 | 99.50K |
| Cost of Revenue | - | 17.30K | 14.46K | 400.20K | 0 | 10.04K |
| Gross Profit | - | 43.94K | 181.93K | -464.23K | 0 | 89.46K |
| Operating Expenses | - | 1.03M | 979.71K | 1.20M | 1.28M | 1.45M |
| Operating Income | - | -989.05K | -797.78K | -1.67M | -1.28M | -1.36M |
| EBITDA | - | 139.18K | -570.97K | -876.15K | -1.01M | -1.13M |
| Interest Expense | - | 111.44K | 109.74K | 202.49K | 278.79K | 236.77K |
| Pretax Income | - | -196.37K | -907.32K | -1.35M | -1.55M | -1.59M |
| Tax Provision | - | - | - | - | - | - |
| Net Income | - | -196.37K | -907.32K | -1.35M | -1.55M | -1.59M |
| Diluted EPS | -0.30 | -0.06 | -0.30 | - | -0.60 | -0.49 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Revenue | - | 80.72K | 181.09K | 389.85K | 426.30K |
| Cost of Revenue | - | 26.80K | -19.14K | 118.94K | 494.43K |
| Gross Profit | - | 53.92K | 200.23K | 270.91K | -68.13K |
| Operating Expenses | - | 7.44M | 5.47M | 5.88M | 4.54M |
| Operating Income | - | -7.39M | -5.27M | -5.61M | -4.61M |
| EBITDA | - | -7.03M | -4.42M | -4.74M | -2.23M |
| Interest Expense | - | 27.99K | 43.71K | 429.34K | 531.68K |
| Pretax Income | - | -7.35M | -5.19M | -6.04M | -3.71M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -7.35M | -5.19M | -6.04M | -3.71M |
| Diluted EPS | - | -2.70 | -1.80 | -2.10 | -1.20 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 16.82M | 16.49M | 14.55M | 15.21M |
| Current Assets | - | 2.43M | 2.43M | 1.23M | 1.83M |
| Cash & Equivalents | - | 1.89M | 1.34M | 103.66K | 1.15M |
| Inventory | - | 264.72K | 779.27K | 894.82K | 310.39K |
| Receivables | - | 98.70K | 165.74K | 124.15K | 95.05K |
| Total Liabilities | - | 797.66K | 3.28M | 4.98M | 8.64M |
| Current Liabilities | - | 728.18K | 1.61M | 3.22M | 8.48M |
| Long Term Debt | - | - | 1.64M | 1.76M | - |
| Total Debt | - | 157.58K | 1.71M | 2.75M | 6.52M |
| Total Equity | - | 16.02M | 13.21M | 9.58M | 6.57M |
| Shares Outstanding | - | 2.70M | 2.90M | 3.16M | 3.22M |
Cash Flows (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -4.58M | -3.60M | -4.28M | -2.63M |
| Investing Cash Flow | - | -3.15M | -706.02K | -154.02K | -88.38K |
| Financing Cash Flow | - | 1.19M | 3.76M | 3.19M | 3.76M |
| Capital Expenditure | - | -7.15M | -804.23K | -152.39K | -88.38K |
| Free Cash Flow | - | -11.73M | -4.41M | -4.43M | -2.72M |
| Net Change in Cash | - | -6.54M | -543.80K | -1.24M | 1.04M |
Ratios (Annual)
Figures in %.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 66.8% | 110.6% | 69.5% | -16.0% |
| Operating Margin % | - | -9,155.2% | -2,911.5% | -1,438.8% | -1,081.9% |
| Net Margin % | - | -9,106.9% | -2,868.5% | -1,548.3% | -870.8% |
| ROE % | - | -45.9% | -39.3% | -63.0% | -56.5% |
| ROCE % | - | -45.9% | -35.4% | -49.5% | -68.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for OPTH
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE8zMDVxYUNScVNzMUM1Z01IMTVtazRUVk40czRkcUxNd21KVks3bXlUUF9JazlldmNIelp5RFA4T0xJVTQyQWtGSGd4YzRubjkw?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Top Optimi Health (OPTH) Competitors 2026 - MarketBeat
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxNZTdJQWcySDJpLURycGVlRmJoRlhaMG12U0pCZ3I4aE1WT1VRb2VtOFdfdnl6d2hDZFpOOHpRc1A0RGtDX3RIeUZGVnhYUVBwYlRrYmFsdjBrcnhtcTBfWjdvdU02Vnp0Rm9XVWxMSXpWaGxCZzFKSjdvakhNVHBEag?oc=5" target="_…
Optimi Health (OPTH) Stock Price, News & Analysis - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE5lRko3c0tMMXBZVlFKVGtEM2ZwUmRSVFFmOTBpRTJzbEZBN0JYaEwwNFhab3ZPaGxJd3NLVS1FRUVUenI4OE9ONk9EdWtpeG1hY0tr?oc=5" target="_blank">Optimi Health (OPTH) Stock Price, News & Analysis</a>&n…
Optimi Health Corp. (OPTH) Total Expenses (Quarterly) - Zacks Investment Research
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxPb01tZkdwYXA2S2U5Sm9pbTBsYWdlQUp0di1rc19DMVNYRUZLTkxFUUk2bGNvcDlNM195RzB5VjRnMlYtbVNpbEZUYUZHby1VcDdPWTF2a3hNd1FWTmtwUzRLTDlDTmlWNDUwYnhvOWdrVnMwUFNSNERwVTB1b1Q0aw?oc=5" target="_…
3 Psychedelic Stocks With Potential Clinical Trial Catalysts - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxQRENsbFdDdDMySVNabVVYZDJlS1lKOXVZTjZmeW5WQW0ydmIwaGozYVQ4YzJUOUJaQVQ0MzlDb1Y1d1d2NnZtWDFzY2wwOG4yaEhlb2lzel93Tlh5M2U4cm1KRk9sTTNVdV9FZFRvMDJfUnJRQmpsc0lMRTZkZXE3UnNVWmJ2WTJJaDkxUU…
OPTH | Optimi Health Corp. Common Stock Data, Price & News - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE1EbXB1MWthTXpMREhVcTl2WHVQdmRUejY2czZIaG92S0dXZFVYRjBTejNhNTRVQUJBUE5yR2pHdHVJM09WVnV1TXB5Xy16YWdx?oc=5" target="_blank">OPTH | Optimi Health Corp. Common Stock Data, Price & News<…
OPTH — Frequently Asked Questions
What is the current share price of OPTH?
As of 2026-08-05 17:25 PDT, OPTH trades at $5.05 on NASDAQ/NYSE. Its 52-week range is $4.01 to $6.08.
What is the market capitalisation of OPTH?
OPTH has a market capitalisation of $16.27M on NASDAQ/NYSE.
What is the P/E ratio of OPTH?
OPTH trades at a trailing price-to-earnings (P/E) ratio of -4.21. Its price-to-book (P/B) ratio is 2.48.
What is the return on equity (ROE) of OPTH?
OPTH has a return on equity (ROE) of -56.49%. Its return on capital employed (ROCE) is -68.54%.
Is OPTH a good stock to buy?
This page provides a data-driven analysis of OPTH, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.